Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel
you are here: HomeNewsBusiness

Coronavirus pandemic | 75% of TCS' workforce to work from home permanently by 2025: Report

Before lockdown, 20 percent of TCS workforce worked from home, now due to the lockdown the company moved 90 percent to work from home
Apr 25, 2020 / 05:05 PM IST

Tata Consultancy Services (TCS) has said that 75 percent or 4.48 lakh of global its workforce (including 3.5 lakh in India) will work from home permanently by 2025, as per a Business Today report.

"We don't believe that we need more than 25% of our workforce at our facilities in order to be 100% productive," TCS COO NG Subramaniam said in the report. He added that the move will be under a new model called 25/25, which requires far less office space.

This is not a model that will be applied to TCS after the pandemic but something that we aspire to reach by 2025, the company added.

Subramanian added that at any given point of time, only 75 percent of a project team would be in a single location, while the rest would be dispersed.

Before lockdown, 20 percent of TCS workforce worked from home, now due to the lockdown the company moved 90 percent of the teams to work from home through its Secure Borderless Work Spaces (SBWS) operating model.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"We have come out stronger and our model is more proven than ever before," CEO and MD Rajesh Gopinathan told employees in a letter. As per Gopinathan, SBWS had seen 35,000 meetings, 406,000 calls, and 340 lakh messages across the platform.

He was clear, work from home will continue post lockdown, for a majority of the workforce. "It helps organisations become more resilient, because the fully distributed nature of this model is inherently less risky and better suited for business continuity and agility,” he added.
Moneycontrol News
first published: Apr 25, 2020 05:05 pm
Sections